I got this announcement from AAAS today:
Make your voice heard!
We have been asked to relay to the broad scientific community the following opportunity to advise US government policymaking deliberations.
You can read the latest updates at: www.whitehouse.gov/open
The Obama Administration is seeking public input on policies concerning access to publicly-funded research results, such as those that appear in academic and scholarly journal articles. Currently, the National Institutes of Health require that research funded by its grants be made available to the public online at no charge within 12 months of publication. The Administration is seeking views as to whether this policy should be extended to other science agencies and, if so, how it should be implemented.
The Office of Science and Technology Policy in the Executive Office of the President and the White House Open Government Initiative are launching a “Public Access Policy Forum” to invite public participation in thinking through what the Federal government’s policy should be with regard to public access to published federally-funded research results.
To that end, OSTP will conduct an interactive, online discussion beginning Thursday, December 10. The discussion will focus on three major areas of interest:
* Implementation (Dec. 10 to 20): Which Federal agencies are good candidates to adopt Public Access policies? What variables (field of science, proportion of research funded by public or private entities, etc.) should affect how public access is implemented at various agencies, including the maximum length of time between publication and public release? Add your comments
You will want to read the Terms of Participation and will need to register a new account and log in using the link at the bottom of the page to comment. Tips on how to comment and moderate posts are listed in the right-hand column. * Features and Technology (Dec. 21 to Dec 31): In what format should the data be submitted in order to make it easy to search and retrieve information, and to make it easy for others to link to it? Are there existing digital standards for archiving and interoperability to maximize public benefit? How are these anticipated to change?
* Management (Jan. 1 to Jan. 7): What are the best mechanisms to ensure compliance? What would be the best metrics of success? What are the best examples of usability in the private sector (both domestic and international)? Should those who access papers be given the opportunity to comment or provide feedback?
Each of these topics will form the basis of a blog posting that will appear at www.whitehouse.gov/open and will be open for comment on the OSTP blog at blog.ostp.gov.
Sincerely, Alan I. Leshner, CEO, AAAS and Executive Publisher, Science
Oxford University’s previous Charles Simonyi Professor for Public Understanding of Science, Richard Dawkins, visited Michigan State University in East Lansing on March 2nd and 3rd. Prof. Dawkins gave a lecture on “The Purpose of Purpose” to a sold-out crowd at the Wharton Center on the evening of the 2nd, and held an hour-and-a-half question and answer session at the Fairchild Theater on campus in the morning of the 3rd.
One thing I love about this place is how random interesting tangents will spring up in the comments. I wrote a brief post awhile back about some funny/sad
Have you ever wondered how Kevin Bacon and the lights of fireflies related to malaria and power grids? I know it’s something that’s kept me up many a sleepless night. One word: interconnections.
Similarly, Duncan Watts first became interested in the “small world problem”—the idea that all of us are more closely connected than we realize—after watching fireflies flash in synchrony, and wondering how they accomplished that. What Watts, Strogatz, Milgram, and others were investigating boiled down to a series of links in a network—hubs and connectors. As Watts and Strogatz showed in their 1998 paper, all it took to make a “small world” from a regular network was the addition of a few “short cuts” (see figure from their paper, right). This elegant and seemingly simple structure of networks explains not only connections between movie stars and
I discussed
Carl Zimmer has a post today about
Ebola is one of my favorite pathogens. With the reputation it has, many people assume it’s killed many more worldwide than it actually has. People hear of Ebola and all kinds of grotesque images come to mind: organs “liquefying” (doesn’t really happen quite like that); bleeding from every orifice (okay, that one can be on-target); the victims dying a horrible death from a virus with an incredibly high mortality rate. There are four known subtypes of Ebola, named for their place of isolation: Ebola Reston, Ivory Coast, Sudan, and Zaire. Together with their cousin, the Marburg virus, they make up the family of viruses known as filoviruses.
It’s always nice when there’s a groundbreaking article in the literature, and the subject just happens to be your baby. My current research focuses on
Anyone working in the area of influenza virus epidemiology is familiar with the name Robert Webster. A virologist at St. Jude’s Children’s Hospital in Memphis, the native New Zealander has been leading the charge against influenza for well over 40 years. Barely out of graduate school, Webster hypothesized that something like genetic reassortment (which had not yet been discovered) occurred to cause the big changes that appeared among human influenza viruses, driving pandemics. He performed a simple experiment that cemented the course of his career: he found that serum from patients who had survived the 1957 influenza pandemic reacted with avian influenza viruses. Later genetic analyses showed that the “Asian flu” virus had indeed received 3 of its 8 gene segments from birds. It happened again in 1968: the pandemic virus was the result of a reassortment between human and avian influenza viruses. These observations led to more than 30 years of surveillance of waterfowl in many different countries, and the revelation that these waterfowl constitute a reservoir of all known subtypes of influenza virus.